NPPA asks for Price Movement details of Orthopedic Implants

Published On 2015-07-05 10:53 GMT | Update On 2015-07-05 10:53 GMT

National Pharmaceutical Pricing Authority (NPPA) to tighten its control on Device Manufacturers.

It all began with a letter from NPPA pointing out to rumours of orthopaedic implants being sold at exorbitant prices with high profit/trade margin. It pointed out to Para 20 of DPCO,2013 saying that manufacturers/ importer/distributor is allowed to increase the MRP of a non-scheduled drug not more than 10% in a year and if they do, the entire increased amount along with interest has to be deposited and penalty shall be imposed. Further it asked manufacturers/importers to issue a price list and supplementary list and not to charge more than the mentioned prices either in the list or on the label, whichever is less.

Some companies reacted to the letter, by asking whether provisions of DPCO are actually applicable to medical devices since its meant for drugs. NPPA clarified this by a letter dates 30/06/2015 that orthopaedic implants along with other medical devices are notified as "Drug" under the Drug and Cosmetic act,1940 and rules thereunder.

NPPA hence decided to seek information regarding the price violation, if any, in respect of notified medical devices manufactured/ imported/ marketed by the companies, NPPA said, asking for the product specification for different types of notified medical devices manufactured or imported by the company.

You can find the copy of the letter on the link below:-

http://www.nppaindia.nic.in/

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She is a member of the Association of Healthcare Journalists. She can be contacted at meghna@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

NPPA asks for Price Movement details of Orthopedic Implants

Similar News

Odisha CM inugurates 73 Ama Hospitals and dialysis centres in 15 Odisha districts

Unfortunate: PG Orthopedic Student at SSKM Hospital succumbs to dengue

GMC Rajouri gets dermatology wing to treat skin related cancer, diseases

LLRM Medical College: Another doctor booked for beating up patient kin

NHA Posts Decentralized Health Protocol (DHP) on Github platform asks private players to commit

Pregabalin effective in relieving symptoms in Functional Dyspepsia, finds study

JnK starts District Residency Program for PG Medical Students

Arthritis Drug linked to Heart-Related Problems and Cancer by FDA